Project: Platform for Blue Cell isolation from autologous adipose tissue for effective regenerative therapy
| Acronym | Blue4Therapy (Reference Number: 114244) |
| Duration | 15/10/2020 - 15/04/2023 |
| Project Topic | Blue4Therapy aims to deliver an innovative platform – BlueSORT - to enable the therapeutic use of a specific type of Adipose Derived Regenerative Cells (ADRCs) - Blue Cells - for Point-of-Care (PoC) treatment of chronic conditions with poor treatment options. BlueSORT will for the first time allow a cost-effective way to isolate autologous Blue Cells, enabling novel research and therapeutic avenues. RT has filed a patent for global use and exploitation rights of Blue Cells. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 13 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | AcouSort AB | Partner | Sweden |
| 2 | Blue Cell Therapeutics ApS | Coordinator | Denmark |
| 3 | NOVOZYMES A/S | Partner | Denmark |
| 4 | Syddansk Universitet | Partner | Denmark |